SCHEMBL7974024

SCHEMBL7974024

Cc1nc(O)c2c(ncn2Cc2ccccc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.46
SMN1; SMN2 Q16637 6/20 0.46
ALDH1A1 P00352 2/20 0.46
GAA P10253 2/20 0.43
ADORA2B P29275 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP11B1 P15538 2/20 0.42
CYP11B2 P19099 2/20 0.42
TNF P01375 1/20 0.42
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.41
PARN O95453 1/20 0.41
CNOT7 Q9UIV1 1/20 0.41
LMNA P02545 2/20 0.39
POLB P06746 1/20 0.39
HIF1A Q16665 1/20 0.39
YTHDC1 Q96MU7 1/20 0.39
HTT P42858 2/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985404 0.85 HPGD (0.49) HPGDSMN1; SMN2ALDH1A1GAAADORA2B
SCHEMBL7975252 0.83 HPGD (0.45) HPGDSMN1; SMN2ALDH1A1GAAADORA2B
SCHEMBL7989407 0.82 HPGD (0.44) HPGDSMN1; SMN2ALDH1A1GAAADORA2B
SCHEMBL7985325 0.82 HPGD (0.42) HPGDSMN1; SMN2ALDH1A1GAAADORA2B
SCHEMBL7975267 0.82 SMN1; SMN2 (0.46) HPGDSMN1; SMN2ALDH1A1GAAADORA2B
SCHEMBL7985471 0.81 HPGD (0.43) HPGDSMN1; SMN2ALDH1A1GAAADORA2B
SCHEMBL7988099 0.81 SMN1; SMN2 (0.45) HPGDSMN1; SMN2ALDH1A1GAAADORA2B
SCHEMBL7985343 0.80 GAA (0.44) HPGDSMN1; SMN2ALDH1A1GAAADORA2B
SCHEMBL7984365 0.80 HPGD (0.45) HPGDSMN1; SMN2ALDH1A1GAAADORA2B
SCHEMBL7984888 0.80 HPGD (0.41) HPGDSMN1; SMN2ALDH1A1GAAADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed